Vonoprazanversusconventional proton pump inhibitor-based triple therapy as first-line treatment againstHelicobacter pylori: A multicenter retrospective study in clinical practice
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vonoprazanversusconventional proton pump inhibitor-based triple therapy as first-line treatment againstHelicobacter pylori: A multicenter retrospective study in clinical practice
Authors
Keywords
-
Journal
Journal of Digestive Diseases
Volume 17, Issue 10, Pages 670-675
Publisher
Wiley
Online
2016-08-18
DOI
10.1111/1751-2980.12398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy
- (2016) Sho Suzuki et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study
- (2016) Kazunari Murakami et al. GUT
- The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase
- (2015) D. R. Scott et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Letter: promising results ofHelicobacter pylorieradication with vonoprazan-based triple therapy after failure of proton pump inhibitor-based triple therapy
- (2015) T. Inaba et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the global emergence ofHelicobacter pyloriantibiotic resistance
- (2015) I. Thung et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
- (2015) Hirotoshi Echizen CLINICAL PHARMACOKINETICS
- The Diagnostic Validity of Citric Acid-Free, High Dose13C-Urea Breath Test AfterHelicobacter pyloriEradication in Korea
- (2015) Yong Hwan Kwon et al. HELICOBACTER
- Hp-normogram (normo-graham) for Assessing the Outcome ofH. pyloriTherapy: Effect of Resistance, Duration, and CYP2C19 Genotype
- (2015) David Y. Graham HELICOBACTER
- Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan forHelicobacter pylori
- (2015) Koji Kamiya et al. JOURNAL OF DERMATOLOGY
- Distribution of intestinal metaplasia as a predictor of gastric cancer development
- (2015) Satoki Shichijo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
- (2015) Yuuichi Sakurai et al. Clinical and Translational Gastroenterology
- Effect ofHelicobacter pyloriEradication on Metachronous Gastric Cancer after Endoscopic Resection of Gastric Tumors: A Meta-Analysis
- (2014) Seung Bae Yoon et al. HELICOBACTER
- Changes in the first lineHelicobacter pylorieradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (TokyoHelicobacter pyloristudy group)
- (2014) Takashi Kawai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials
- (2014) A. C. Ford et al. BMJ-British Medical Journal
- Helicobacter pylori Infection Is Strongly Associated With Gastric and Duodenal Ulcers in a Large Prospective Study
- (2012) Ben Schöttker et al. Clinical Gastroenterology and Hepatology
- Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration
- (2011) Kosuke Sakitani et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised Edition
- (2010) Masahiro Asaka et al. HELICOBACTER
- Annual Change of Primary Resistance to Clarithromycin among Helicobacter pylori Isolates from 1996 through 2008 in Japan
- (2009) Noriyuki Horiki et al. HELICOBACTER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started